At Sechenov University, researchers introduced a new emollient cream designed to replace imports with a formulation that softens the skin and eliminates dryness, flaking, itching, and a tight feeling. The product is suitable for a wide range of skin conditions, including atopic dermatitis, retinoic dermatitis, and age-related xerosis, which occurs when the skin loses moisture over time. This information came to light through Sechenov University communications via socialbites.ca.
The cream’s formula blends five natural oils—grape seed, rice bran, sweet almond, shea, and mango—together with components that supply essential fatty acids and replenish lipids in the skin. It also features a moisturizing complex (hydroxyethylurea, aloe vera gel, panthenol, arginine, and vitamin E) and humectants (hyaluronic acid and xanthan gum) that drive progressive hydration. Soothing bisabolol calms irritated and sensitive skin, while ceramides help restore the skin’s protective hydrolipid barrier.
Clinical tests demonstrated the emollient’s effectiveness in removing dryness, flaking, itching, and tightness, with no adverse side effects observed during trials.
Officials describe the product as the inaugural item in Sechenov University’s skincare line. The development reflects extensive work in physical colloidal chemistry and soft-form technology. Plans are in place to advance this field further, including the creation of a cream for vitiligo and an expanded range addressing various skin types. Parallel efforts include two additional topical formulations in cream form, which will utilize the same base and technology, according to Galina Ramenskaya, director of the Institute of Pharmacy at AP.
The product is expected to reach pharmacy shelves in the spring. Marketed as an innovative import-substitution emollient, the cream is positioned for use in cosmetology, dermatology, and preventive medicine.
Earlier, dermatologist Karamova reported an uptick in leprosy cases within Russia, underscoring ongoing dermatological health concerns that such treatments may address.